Displaying broad expertise across the whole spectrum of corporate transactions, including cross-border acquisitions, divestitures, and leveraged buyouts, the Goodwin team is heavily praised for its ‘extremely smart, capable, and well-informed’ approach. The practice frequently provides strategic counsel on various shareholder-related issues, including proxy contests, activism, and shareholder litigation, with Boston-based global chair of M&A Stuart Cable noted as an expert in the life sciences sector. Lisa Haddad routinely represents buyers, sellers, and financial advisors, while Jacqueline Mercier focuses on complex corporate governance issues. Also based out of Boston, John Haggerty and Deborah Birnbach co-chair the public M&A offering. From Silicon Valley, Lawrence Chu brings vast experience in handling joint venture arrangements and recapitalizations, while New York-based Joshua Zachariah is highly knowledgeable in the tech and private equity spheres. Alessandra Love Simons left the firm in November 2023.
Testimonials
Collated independently by Legal 500 research team.
‘Teams we work with are extremely smart, capable, and well-informed. Great business sense, direct in advice.’
‘Stuart Cable -- eminence grise of the life sciences M&A market.’
Key clients
- Marlin Equity Partners
- Concert Pharmaceuticals
- OEG Offshore
- InTandem
- SurePrep
- RoadOne IntermodaLogistics
- NextAir Holding
- Royalty Pharma
- Alert Innovation
Work highlights
- Advised Concert Pharmaceuticals on its $576m sale to Sun Pharma.
- Advised InTandem on the sale of its portfolio company, Paradigm, to Pioneer BidCo, LLC, a newly formed company backed by BlackRock.
- Advised Alert Innovation on its definitive agreement to be acquired by Walmart.
Lawyers
Practice head
The lawyer(s) leading their teams.
Stuart Cable, Lisa Haddad, John Haggerty, Deborah Birnbach, Lawrence Chu, Joshua Zachariah